Bartronics India Limited has informed the Exchange regarding a press release dated March 06, 2026, titled "Avio Smart Market Stack, Huwel Lifesciences to Launch Patented Molecular Diagnostic Products Across Healthcare Segments".
ASMS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Avio Smart Market Stack (ASMS, formerly Bartronics India) has expanded its collaboration with Huwel Lifesciences to commercialize patented molecular diagnostic products across India, including RT-PCR kits, point-of-care molecular testing devices, and disease detection panels for tuberculosis, HIV, HPV/cervical cancer, hepatitis, and antimicrobial resistance surveillance. The move follows a recently signed Shareholders' Agreement between the two firms. Huwel's tuberculosis diagnostic platform has already received the required regulatory approvals, with several additional patents and products in development. ASMS will handle go-to-market strategy, institutional engagement, and commercialization, leveraging existing RT-PCR lab infrastructure built during COVID-19. The addressable market for infectious disease diagnostics in India is estimated at over ₹5,000 crore annually. The company has also rebranded from Bartronics India Limited to Avio Smart Market Stack Limited and is building a rural digital operating platform alongside this health-tech push.
This signals a strategic pivot into health-tech and diagnostics for the company, potentially opening a new growth vertical. The rebrand to Avio Smart Market Stack reflects a broader identity shift beyond its legacy Bartronics business, which may attract fresh investor interest though commercial success and revenue contribution remain to be demonstrated.